Drug treatment for spinal muscular atrophy types II and III-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug treatment for spinal muscular atrophy types II and III

Published:2020-01-06 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Wadman Renske I¹,van der Pol W Ludo¹,Bosboom Wendy MJ²,Asselman Fay-Lynn¹,van den Berg Leonard H¹,Iannaccone Susan T³,Vrancken Alexander FJE¹

Affiliation:

1. University Medical Center Utrecht, Brain Center Rudolf Magnus; Department of Neurology; Heidelberglaan 100 Utrecht Netherlands 3584 CX

2. Onze Lieve Vrouwe Gasthuis locatie West; Department of Neurology; Amsterdam Netherlands

3. University of Texas Southwestern Medical Center; Department of Pediatrics; 5323 Harry Hines Boulevard Dallas Texas USA 75390

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006282.pub5/epdf/full

Reference285 articles.

1. Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial;Bertini;Lancet Neurology,2017

2. NCT01302600 Safety and efficacy of olesoxime (TRO19622) in 3-25 years SMA patients clinicaltrials.gov/ct2/show/NCT01302600

3. Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy;Chen;Neurology,2010

4. NCT00485511 A trial of hydroxyurea in spinal muscular atrophy clinicaltrials.gov/ct2/show/NCT00485511

5. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study;Kirschner;Neuromuscular Disorders,2014

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ANALYSIS OF THE EFFECTIVENESS OF PATHOGENETIC PHARMACOTHERAPY FOR SPINAL MUSCULAR ATROPHY IN CHILDREN IN THE CHUVASH REPUBLIC;Acta medica Eurasica;2023-09-25

2. New Efforts to Demonstrate the Successful Use of TRH as a Therapeutic Agent;International Journal of Molecular Sciences;2023-07-04

3. Muscle impairment in MRI affect variability in treatment response to nusinersen in patients with spinal muscular atrophy type 2 and 3: A retrospective cohort study;Brain and Development;2023-03

4. Efectividad clínica y seguridad del cribado neonatal de la atrofia muscular espinal. Revisión sistemática;2023

5. Nusinersen for spinal muscular atrophy types II and III: a retrospective single-center study in South Korea;World Journal of Pediatrics;2022-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3